{
  "paper_metadata": {
    "pmid": "27148582",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted genetic variant information for BRCA2, including penetrance data."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": null,
      "protein_notation": "p.V2466R",
      "genomic_position": null,
      "clinical_significance": "VUS",
      "patients": {
        "count": 1,
        "demographics": "66-year-old Caucasian male",
        "phenotype": "male breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 66,
          "age_at_onset": null,
          "age_at_diagnosis": 66,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "diagnosed with hormone receptor-positive (HR+)/HER2\u2212 stage IIIA invasive ductal carcinoma",
          "evidence_sentence": "A 66-yr-old Caucasian man underwent a right radical mastectomy and sentinel lymph node biopsy for an infiltrative breast carcinoma of papillary histotype."
        }
      ],
      "functional_data": {
        "summary": "No clear breast cancer susceptibility loci identified; contradictory studies suggest potential risk.",
        "assays": []
      },
      "segregation_data": null,
      "population_frequency": null,
      "evidence_level": "low",
      "source_location": "Results, paragraph 4",
      "additional_notes": "Variant is classified as a variant of uncertain significance (VUS).",
      "key_quotes": [
        "None are clear breast cancer susceptibility loci; however, certain contradictory studies have suggested that these BRCA2 polymorphisms may or may not confer increased risk."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": null,
      "protein_notation": "p.N372H",
      "genomic_position": null,
      "clinical_significance": "VUS",
      "patients": {
        "count": 1,
        "demographics": "66-year-old Caucasian male",
        "phenotype": "male breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P2",
          "age_at_evaluation": 66,
          "age_at_onset": null,
          "age_at_diagnosis": 66,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "diagnosed with hormone receptor-positive (HR+)/HER2\u2212 stage IIIA invasive ductal carcinoma",
          "evidence_sentence": "A 66-yr-old Caucasian man underwent a right radical mastectomy and sentinel lymph node biopsy for an infiltrative breast carcinoma of papillary histotype."
        }
      ],
      "functional_data": {
        "summary": "No clear breast cancer susceptibility loci identified; contradictory studies suggest potential risk.",
        "assays": []
      },
      "segregation_data": null,
      "population_frequency": null,
      "evidence_level": "low",
      "source_location": "Results, paragraph 4",
      "additional_notes": "Variant is classified as a variant of uncertain significance (VUS).",
      "key_quotes": [
        "None are clear breast cancer susceptibility loci; however, certain contradictory studies have suggested that these BRCA2 polymorphisms may or may not confer increased risk."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 2,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "Extracted all relevant BRCA2 variants and penetrance data."
  }
}